Third Quarter Financial Report - 2018

Gentian Diagnostics AS announces its results for the third quarter of 2018. The highlights include:

• Total revenues of MNOK 18.4 including a one-off license revenue of MNOK 6.2
• Record sales revenues of MNOK 10.4 for the quarter
• 55% growth in underlying sales revenue compared to 3Q17, 43 % year to date
• Clinical study program for GCAL is progressing according to plan

Please find the report GD-3Q2018-Interim-report.

For further information, please contact:

Hilja Ibert
CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no
Cell Phone: +47 919 05 242

Njaal Kind
CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone: +47 919 06 525